Page 180 - IJB-10-6

International Journal of Bioprinting 3D bioprinting technology for brain tumor

doi: 10.1007/s11154-020-09551-y doi: 10.5772/intechopen.81552
123. Erasimus H, Gobin M, Niclou S, Van Dyck E. DNA repair 134. Hagenbuchner J, Nothdurfter D, Ausserlechner MJ. 3D
mechanisms and their clinical impact in glioblastoma. bioprinting: novel approaches for engineering complex
Mutat Res Rev Mutat Res. 2016;769:19-35. human tissue equivalents and drug testing. Essays Biochem.
doi: 10.1016/j.mrrev.2016.05.005 2021;65(3):417-427.
doi: 10.1042/EBC20200153
124. Shu J, Wang X, Yang X, Zhao G. Author correction: ATM
inhibitor KU60019 synergistically sensitizes lung cancer 135. Sunildutt N, Parihar P, Chethikkattuveli Salih AR, Lee SH,
cells to topoisomerase II poisons by multiple mechanisms. Choi KH. Revolutionizing drug development: harnessing the
Sci Rep. 2024;14(1):8785. potential of organ-on-chip technology for disease modeling
doi: 10.1038/s41598-024-59332-9 and drug discovery. Front Pharmacol. 2023;14:1139229.
doi: 10.3389/fphar.2023.1139229
125. Wang C, Li J, Sinha S, Peterson A, Grant GA, Yang F.
Mimicking brain tumor-vasculature microanatomical 136. Peng W, Datta P, Ayan B, Ozbolat V, Sosnoski D, Ozbolat
architecture via co-culture of brain tumor and endothelial IT. 3D bioprinting for drug discovery and development in
cells in 3D hydrogels. Biomaterials. 2019;202:35-44. pharmaceutics. Acta Biomater. 2017;57:26-46.
doi: 10.1016/j.biomaterials.2019.02.024 doi: 10.1016/j.actbio.2017.05.025
126. Nguyen T, Sarkar T, Tran T, Moinuddin SM, Saha D, 137. Satpathy A, Datta P, Wu Y, Ayan B, Bayram E, Ozbolat IT.
Ahsan F. Multilayer soft photolithography fabrication of Developments with 3D bioprinting for novel drug discovery.
microfluidic devices using a custom-built wafer-scale PDMS Expert Opin Drug Discov. 2018;13(12):1115-1129.
slab aligner and cost-efficient equipment. Micromachines doi: 10.1080/17460441.2018.1542427
(Basel). 2022;13(8):1357. 138. Yun EJ, Kim S, Hsieh JT, Baek ST. Wnt/beta-catenin signaling
doi: 10.3390/mi13081357
pathway induces autophagy-mediated temozolomide-
127. Neufeld L, Yeini E, Reisman N, et al. Microengineered resistance in human glioblastoma. Cell Death Dis.
perfusable 3D-bioprinted glioblastoma model for in 2020;11(9):771.
vivo mimicry of tumor microenvironment. Sci Adv. doi: 10.1038/s41419-020-02988-8
2021;7(34):eabi9119. 139. Song Q, Peng S, Sun Z, Heng X, Zhu X. Temozolomide drives
doi: 10.1126/sciadv.abi9119
ferroptosis via a DMT1-dependent pathway in glioblastoma
128. Schober AL, Wicki-Stordeur LE, Murai KK, Swayne LA. cells. Yonsei Med J. 2021;62(9):843-849.
Foundations and implications of astrocyte heterogeneity doi: 10.3349/ymj.2021.62.9.843
during brain development and disease. Trends Neurosci. 140. Karve AS, Desai JM, Gadgil SN, et al. A review of
2022;45(9):692-703. approaches to potentiate the activity of temozolomide
doi: 10.1016/j.tins.2022.06.009
against glioblastoma to overcome resistance. Int J Mol Sci.
129. Slika H, Karimov Z, Alimonti P, et al. Preclinical models and 2024;25(6):3217.
technologies in glioblastoma research: evolution, current doi: 10.3390/ijms25063217
state, and future avenues. Int J Mol Sci. 2023;24(22):16316. 141. Ibarra LE, Vilchez ML, Caverzan MD, Milla Sanabria LN.
doi: 10.3390/ijms242216316
Understanding the glioblastoma tumor biology to optimize
130. Jung S, Jo H, Hyung S, Jeon NL. Advances in 3D photodynamic therapy: From molecular to cellular events. J
vascularized tumor-on-a-Chip technology. Adv Exp Med Neurosci Res. 2021;99(4):1024-1047.
Biol.2022;1379:231-256. doi: 10.1002/jnr.24776
doi: 10.1007/978-3-031-04039-9_9
142. Reed MR, Maddukuri L, Ketkar A, et al. Inhibition of
131. Li W, Zhou Z, Zhou X, et al. 3D biomimetic models to tryptophan 2,3-dioxygenase impairs DNA damage tolerance
reconstitute tumor microenvironment in vitro: spheroids, and repair in glioma cells. NAR Cancer. 2021;3(2):zcab014.
organoids, and tumor‐on‐a‐chip. Adv Healthc Mater. doi: 10.1093/narcan/zcab014
2023;12(18):2202609. 143. Cirri D, Chiaverini L, Pratesi A, Marzo T. Is the next
doi: 10.1002/adhm.202202609
cisplatin already in our laboratory? Comm Inorganic Chem.
132. Langhans SA. Three-dimensional in vitro cell culture models 2023;43(6):465-478.
in drug discovery and drug repositioning. Front Pharmacol. doi: 10.1080/02603594.2022.2152016
2018;9:6. 144. Luo H, Yi T, Huang D, et al. circ_PTN contributes to-
doi: 10.3389/fphar.2018.00006
cisplatin resistance in glioblastoma via PI3K/AKT signaling
133. Joseph JS, Malindisa ST, Ntwasa M. Two-dimensional (2D) through the miR-542-3p/PIK3R3 pathway. Mol Ther Nucleic
and three-dimensional (3D) cell culturing in drug discovery. Acids. 2021;26:1255-1269.
Cell Cult. 2018;2:1-22. doi: 10.1016/j.omtn.2021.08.034

Volume 10 Issue 6 (2024) 172 doi: 10.36922/ijb.4166